Back to top

Image: Bigstock

Amdocs (DOX) Q2 Earnings & Revenues Top Estimates, View Cut

Read MoreHide Full Article

Amdocs Limited (DOX - Free Report) reported second-quarter fiscal 2020 results, wherein both top and bottom lines beat estimates.

Quarterly non-GAAP earnings per share came in at $1.08, up from $1.02 in the year-ago quarter. The bottom line also beat the Zacks Consensus Estimate by 1.89%. The figure came within the company’s guided range of $1.03-$1.09.

Revenues for the quarter came in at $1.05 billion, improving 2.9% year over year. The top line also came within the company’s guided range of $1.035-$1.075 billion and beat the consensus mark of $1.04 billion.

Sequential growth in demand from North America and solid growth in the Rest of the World and Europe drove the results. Moreover, continued addition of new customers and strong project execution boosted revenues.

However, a negative sequential impact of nearly $8 million from foreign currency movements was a headwind.

The company also reduced its fiscal 2020 guidance due to the uncertainties related to the coronavirus pandemic.

Amdocs Limited Price, Consensus and EPS Surprise

Amdocs Limited Price, Consensus and EPS Surprise

Amdocs Limited price-consensus-eps-surprise-chart | Amdocs Limited Quote

Quarter Details

The twelve-month backlog, which includes anticipated revenues related to contracts, estimated revenues from managed service contracts, letters of intent, maintenance and estimated on-going support activities, came in at $3.46 billion during the quarter, down $60 million from the prior quarter.

The company incurred non-GAAP operating expenses of $867.4 million, up 3% from the year-ago quarter.

Non-GAAP operating income increased 1.8% to $181 million.

Balance Sheet & Cash Flow

Cash and cash equivalents as of Mar 31, 2020, were $763 million, up from $485.9 million in the previous quarter.

Cash flow from operating activities was $103 million, down from $163.9 million recorded in the previous quarter. Free cash flow was $57 million.

During the fiscal second quarter, the company repurchased shares worth $120 million. Also, its board of directors recently approved the payment of a quarterly dividend of $0.3275 per share. The dividend will be paid out on Jul 24.


For third-quarter fiscal 2020, Amdocs expects revenues between $990 million and $1.04 billion, assuming approximately an $8-million sequential negative impact from foreign currency fluctuations.

Non-GAAP earnings per share of $1.00-$1.08 are expected for the fiscal third quarter.

For fiscal 2020, the company now expects revenues to be down 0.5% to up 2.5% year over year compared to its earlier projection of growth between 2.5% and 5.5%, with TTS contributing a little more than 1%.

Amdocs expects non-GAAP earnings to be flat to up 4% year over year compared with its previous expectation of 3-7% growth year over year.

Zacks Rank and Stocks to Consider

Amdocs currently carries a Zacks Rank #3 (Hold).

A few better-ranked stocks in the broader technology sector are Advanced Semiconductor Engineering Inc (ASX - Free Report) , NeoPhotonics Corporation (NPTN - Free Report) and Avid Technology, Inc. (AVID - Free Report) , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings growth rate for Advanced Semiconductor, NeoPhotonics and Avid is currently pegged at 26.63%, 15% and 20%, respectively.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>